Search research articles
Contact Us
Filters
Showing results (541-550 of 567) with videos related to
Page
of 57
Sort By:
International Journal of Cancer
|
March 8, 2021
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Daniel Buergy, Florian Würschmidt, Eleni Gkika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2018
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Julia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Nature Methods
|
June 16, 2022
Mass spectrometry-based draft of the mouse proteome
Piero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Neuro-Oncology
|
May 30, 2024
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Josef A Buchner, Florian Kofler, Michael Mayinger, et al.
Cancers
|
June 24, 2022
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Shivaprasad Patil, Annett Linge, Hannah Hiepe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 11, 2020
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland
Christiane Matuschek, Johannes C Fischer, Stephanie E Combs, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Annett Linge, Fabian Lohaus, Steffen Löck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 567) with videos related to
Sort By:
Page
of 57
International Journal of Cancer
|
March 8, 2021
Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis
Daniel Buergy, Florian Würschmidt, Eleni Gkika, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2018
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Julia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2016
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Annett Linge, Steffen Löck, Volker Gudziol, et al.
Nature Methods
|
June 16, 2022
Mass spectrometry-based draft of the mouse proteome
Piero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis
Simon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
Neuro-Oncology
|
May 30, 2024
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Josef A Buchner, Florian Kofler, Michael Mayinger, et al.
Cancers
|
June 24, 2022
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Shivaprasad Patil, Annett Linge, Hannah Hiepe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
September 11, 2020
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland
Christiane Matuschek, Johannes C Fischer, Stephanie E Combs, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2016
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Annett Linge, Fabian Lohaus, Steffen Löck, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
Simon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
Page
of 57